Opyl Limited (ASX:OPL – Get Free Report) insider Antanas (Tony) Guoga bought 1,500,000 shares of the business’s stock in a transaction on Wednesday, December 11th. The stock was bought at an average price of A$0.03 ($0.02) per share, with a total value of A$45,000.00 ($27,950.31).
Opyl Stock Performance
About Opyl
Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials.
Read More
- Five stocks we like better than Opyl
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What Investors Need to Know About Upcoming IPOs
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What is a buyback in stocks? A comprehensive guide for investors
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Opyl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opyl and related companies with MarketBeat.com's FREE daily email newsletter.
